Then, only limited genetic screening was performed for highly recurrent P/LPVs in BRCA1 and BRCA2 detected in Slovenian HBOC families [11] and extended genetic analysis was limited only to those with a substantial family history of breast and/or ovarian cancer [9]. This evidence concerns the gene BRCA2 and ovarian carcinoma.